Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control

Stefan A Baeten; Rob M P M Baltussen; Carin A Uyl-de Groot; John Bridges; Louis W Niessen

doi:10.1111/j.1524-4733.2010.00718.x

Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control

Stefan A Baeten, Rob M P M Baltussen, Carin A Uyl-de Groot, John Bridges, Louis W Niessen

Research output: Contribution to journal › Article › peer-review

35 Citations (Scopus)

Abstract

The past decade, medical technology assessment focused on cost-effectiveness analysis, yet there is an increasing need to consider equity implications of health interventions as well. This article addresses three equity-efficiency trade-off methods proposed in the literature. Moreover, it demonstrates their impact on cost-effectiveness analyses in current breast cancer control options for women of different age groups.

Original language	English
Pages (from-to)	573-579
Number of pages	7
Journal	Value in Health
Volume	13
Issue number	5
DOIs	https://doi.org/10.1111/j.1524-4733.2010.00718.x
Publication status	Published - Aug 2010

Keywords

Age Factors
Aged
Breast Neoplasms
Cost-Benefit Analysis
Decision Support Techniques
Efficiency
Female
Health Services Accessibility
Health Status Disparities
Humans
Markov Chains
Models, Economic
Neoplasm Staging
Netherlands
Quality-Adjusted Life Years
World Health Organization

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/j.1524-4733.2010.00718.x

Cite this

@article{be964f1a3aa64bfc92a65710b804862f,

title = "Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control",

abstract = "The past decade, medical technology assessment focused on cost-effectiveness analysis, yet there is an increasing need to consider equity implications of health interventions as well. This article addresses three equity-efficiency trade-off methods proposed in the literature. Moreover, it demonstrates their impact on cost-effectiveness analyses in current breast cancer control options for women of different age groups.",

keywords = "Age Factors, Aged, Breast Neoplasms, Cost-Benefit Analysis, Decision Support Techniques, Efficiency, Female, Health Services Accessibility, Health Status Disparities, Humans, Markov Chains, Models, Economic, Neoplasm Staging, Netherlands, Quality-Adjusted Life Years, World Health Organization",

author = "Baeten, {Stefan A} and Baltussen, {Rob M P M} and {Uyl-de Groot}, {Carin A} and John Bridges and Niessen, {Louis W}",

year = "2010",

month = aug,

doi = "10.1111/j.1524-4733.2010.00718.x",

language = "English",

volume = "13",

pages = "573--579",

journal = "Value in Health",

issn = "1098-3015",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Incorporating equity-efficiency interactions in cost-effectiveness analysis-three approaches applied to breast cancer control

AU - Baeten, Stefan A

AU - Baltussen, Rob M P M

AU - Uyl-de Groot, Carin A

AU - Bridges, John

AU - Niessen, Louis W

PY - 2010/8

Y1 - 2010/8

N2 - The past decade, medical technology assessment focused on cost-effectiveness analysis, yet there is an increasing need to consider equity implications of health interventions as well. This article addresses three equity-efficiency trade-off methods proposed in the literature. Moreover, it demonstrates their impact on cost-effectiveness analyses in current breast cancer control options for women of different age groups.

AB - The past decade, medical technology assessment focused on cost-effectiveness analysis, yet there is an increasing need to consider equity implications of health interventions as well. This article addresses three equity-efficiency trade-off methods proposed in the literature. Moreover, it demonstrates their impact on cost-effectiveness analyses in current breast cancer control options for women of different age groups.

KW - Age Factors

KW - Aged

KW - Breast Neoplasms

KW - Cost-Benefit Analysis

KW - Decision Support Techniques

KW - Efficiency

KW - Female

KW - Health Services Accessibility

KW - Health Status Disparities

KW - Humans

KW - Markov Chains

KW - Models, Economic

KW - Neoplasm Staging

KW - Netherlands

KW - Quality-Adjusted Life Years

KW - World Health Organization

U2 - 10.1111/j.1524-4733.2010.00718.x

DO - 10.1111/j.1524-4733.2010.00718.x

M3 - Article

C2 - 20384980

VL - 13

SP - 573

EP - 579

JO - Value in Health

JF - Value in Health

SN - 1098-3015

IS - 5

ER -